STOCK Act disclosures
LGND Ligand Pharmaceuticals Incorporated
Members of Congress who traded or hold Ligand Pharmaceuticals Incorporated, from their STOCK Act disclosures. None of the 13F managers we track hold it, so this page covers Congress only. LGND earnings.
- 1 members traded it since Nov 22, 2023
- 4 / 0 buys / sales
- 0 held it at year end
- May 29, 2026 latest trade
Trades
4 trades since Nov 22, 2023, newest filings first
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded May 29Filed Jun 8 10d
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded Mar 3Filed Apr 7 35d
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded Jan 15Filed Feb 13 29d
-
LGNDLigand Pharmaceuticals IncorporatedBuy$1K–$15KTraded Jan 5Filed Feb 13 39d
No trades match these filters.
Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. See all Congress trades and how we read these reports.